Science Explorer Back to mapMap
Discussion
Company · Wolfenbüttel · Germany

GeneXplain (Germany)

genexplain.comROR OpenAlex
Research works
24
▼ 18% vs 2018-21
Citations
847
35.8 per fractional work
Top-10% rate
7.5%
all institutions 10.0%
Open access
70%
world 40%
International
66%
world 18%
GeneXplain (Germany)

Not ranked overall: GeneXplain (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does GeneXplain (Germany) work in?

In all years, 59% of research at GeneXplain (Germany) is in Life Sciences, 31% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (54%), Medicine (31%), Immunology and Microbiology (4%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 14 fractional works · 58.9% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 53.5% of its workMolecular Biology: 9 fractional works · 39.4% of its workGenetics: 2 fractional works · 9.4% of its workCancer Research: 1 fractional works · 3.0% of its workBiotechnology: 0 fractional works · 1.4% of its workCell Biology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 4.3% of its workImmunology: 1 fractional works · 3.0% of its workVirology: 0 fractional works · 0.7% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.3% of its workMicrobiology: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workFood Science: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workHealth Sciences: 7 fractional works · 31.5% of its workMedicine: 7 fractional works · 31.1% of its workOncology: 1 fractional works · 5.7% of its workPathology and Forensic Medicine: 1 fractional works · 4.9% of its workSurgery: 1 fractional works · 3.4% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.3% of its workGenetics: 1 fractional works · 3.2% of its workDermatology: 0 fractional works · 2.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.9% of its workEpidemiology: 0 fractional works · 1.8% of its workPhysiology: 0 fractional works · 1.1% of its workHepatology: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.7% of its workInternal Medicine: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 7.9% of its workEngineering: 1 fractional works · 3.8% of its workBiomedical Engineering: 1 fractional works · 2.4% of its workElectrical and Electronic Engineering: 0 fractional works · 1.4% of its workComputer Science: 1 fractional works · 3.7% of its workComputational Theory and Mathematics: 1 fractional works · 2.3% of its workArtificial Intelligence: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 0 fractional works · 0.3% of its workEcology: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 1.6% of its workSocial Sciences: 0 fractional works · 1.4% of its workGeography, Planning and Development: 0 fractional works · 0.7% of its workSociology and Political Science: 0 fractional works · 0.7% of its workArts and Humanities: 0 fractional works · 0.2% of its workArcheology: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.0% of its workALL ITS WORKGeneXplain(Germany)24fractional works, all years
Life Sciences59%Physical Sciences8%Health Sciences31%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1353.5%
    2. Immunology and Microbiology14.3%
    3. Neuroscience00.4%
    4. Agricultural and Biological Sciences00.3%
    5. Pharmacology, Toxicology and Pharmaceutics00.3%
    1. Medicine731.1%
    2. Nursing00.3%
    1. Engineering13.8%
    2. Computer Science13.7%
    3. Environmental Science00.3%
    4. Mathematics00.2%
    1. Social Sciences01.4%
    2. Arts and Humanities00.2%
    3. Decision Sciences00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.04× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.43× its world share, 0 worksImmunology and Micro…Neuroscience: 0.27× its world share, 0 worksNeuroscienceComputer Science: 0.31× its world share, 0 worksComputer ScienceEngineering: 0.38× its world share, 0 worksEngineeringMedicine: 2.87× its world share, 4 worksMedicineNursing: 2.50× its world share, 0 worksNursingArts and Humanities: 0.24× its world share, 0 worksArts and HumanitiesSocial Sciences: 0.39× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.0×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology5.04×2 works
  2. Medicine2.87×4 works
  3. Nursing2.50×0 works
  4. Immunology and Microbiology2.43×0 works
  5. Social Sciences0.39×0 works
  6. Engineering0.38×0 works
  7. Computer Science0.31×0 works
  8. Neuroscience0.27×0 works
  9. Arts and Humanities0.24×0 works

Who are the top researchers at GeneXplain (Germany)?

Ranked on the quality score, Alexander E Kel and Philip Stegmaier lead among researchers whose main affiliation is GeneXplain (Germany).

  1. 1 Alexander E Kel Germany · #1,819,379 worldwide 7.4k citations · 228 works
  2. 2 Philip Stegmaier Germany · #3,679,667 worldwide 736 citations · 50 works
All ranked researchers at GeneXplain (Germany)

What are the most cited papers from GeneXplain (Germany)?

The most cited paper from GeneXplain (Germany) is "cutPrimers: A New Tool for Accurate Cutting of Primers from Reads of Targeted Next Generation Sequencing" (Andrey A. Kechin, Uljana A. Boyarskikh, Alexander E Kel et al., 2017), with 1,480 citations. Next come "GTRD: an integrated view of transcription regulation" (314) and "ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis" (234).

Most cited papers
#PaperReleasedCitations
1 cutPrimers: A New Tool for Accurate Cutting of Primers from Reads of Targeted Next Generation Sequencing Andrey A. Kechin, Uljana A. Boyarskikh, Alexander E Kel et al. · Journal of Computational Biology 17 Jul 2017 1,480
2 GTRD: an integrated view of transcription regulation Semyon K. Kolmykov, Ivan Yevshin, Mikhail A. Kulyashov et al. · Nucleic Acids Research Open access 3 Nov 2020 314
3 ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis Yao Shi, Fedor Nikulenkov, Joanna E Zawacka-Pankau et al. · Cell Death and Differentiation Open access 10 Jan 2014 234
4 Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis Fedor Nikulenkov, Clemens Spinnler, H. Li et al. · Cell Death and Differentiation Open access 13 Jul 2012 186
5 TFClass: expanding the classification of human transcription factors to their mammalian orthologs Edgar Wingender, Torsten Schoeps, Martin Haubrock et al. · Nucleic Acids Research Open access 12 Oct 2017 157
All 79 most cited papers, with filters and sorting

Which keywords describe research at GeneXplain (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Expression, Gene Set Enrichment Analysis, Protein-Protein Interaction Networks, Cancer, Synthetic Biology, Pathogenesis, Bioinformatics and Data Analysis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Epidemiology2▲ 2.2×10 topics
  2. Gene Expression2▲ 13×7 topics
  3. Cancer2▲ 5.1×15 topics
  4. Machine Learning2▲ 3.3×3 topics
  5. Gene Set Enrichment Analysis2▲ 188×1 topic
  6. Protein-Protein Interaction Networks2▲ 188×1 topic
  7. Synthetic Biology1▲ 68×2 topics
  8. Bioinformatics1▲ 45×4 topics
  9. Cancer Therapy1▲ 7.8×7 topics
  10. Data Analysis1▲ 16×3 topics
  11. Pathogenesis1▲ 9.3×4 topics
  12. Immunotherapy1▲ 7.1×2 topics
  13. Gene Regulation1▲ 29×2 topics
  14. Normalization1▲ 60×2 topics
  15. Oxidative Stress1▲ 2.4×5 topics
  16. Transcription Factors1▲ 31×2 topics

Which research topics does GeneXplain (Germany) publish most on?

By volume in 2022-now: Genetic factors in colorectal cancer, Glioma Diagnosis and Treatment, Colorectal Cancer Treatments and Studies and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.

Genetic factors in color…1Genetic factors in colorectal cancer: 1 fractional worksGlioma Diagnosis and Tre…0Glioma Diagnosis and Treatment: 0 fractional worksColorectal Cancer Treatm…0Colorectal Cancer Treatments and Studies: 0 fractional worksInterstitial Lung Diseas…0Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional worksDiagnosis and Treatment of Venous Diseases: 0 fractional worksInflammatory Bowel Disease: 0 fractional worksFerroptosis and cancer p…0Ferroptosis and cancer prognosis: 0 fractional worksHuman-Animal Interaction Studies: 0 fractional worksCancer Research and Treatments: 0 fractional worksLiver Diseases and Immun…0Liver Diseases and Immunity: 0 fractional works
Pathology and Forensic MedicineGeneticsOncologyPulmonary and Respiratory Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetic factors in colorectal cancer Pathology and Forensic Medicine 1 works
  2. 2 Glioma Diagnosis and Treatment Genetics 0 works
  3. 3 Colorectal Cancer Treatments and Studies Oncology 0 works
  4. 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  5. 5 Diagnosis and Treatment of Venous Diseases Surgery 0 works
  6. 6 Inflammatory Bowel Disease Genetics 0 works
  7. 7 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  8. 8 Human-Animal Interaction Studies Genetics 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Liver Diseases and Immunity Hepatology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available69.7%not open30.3%

World: 40% of research is openly available.

with international co-authors65.8%domestic only34.2%

World: 18% is written across borders.

How has GeneXplain (Germany)'s research output changed?

Output in 2022-2025 was 18% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is GeneXplain (Germany) as a percentage of every work published that year, 0.000041% in 2024.

still counting0.000050%0.00010%GeneXplain (Germany)0.000022% in 20252020

Fractional works of GeneXplain (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Wolfenbüttel

All research institutions in Wolfenbüttel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about GeneXplain (Germany). Posts are plain text and can be reported.